Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

AIA Singapore appoints Heung-min Son as its first brand ambassador promoting holistic wellness amongst Singaporeans

SINGAPORE, Jan. 13, 2023 /PRNewswire/ -- AIA Singapore today announced Tottenham Hotspur player Heung-min Son, as its firstSingapore brand ambassador. Heung-min Son is a seven time Asian Footballer of the Year and last season became the first Asian player to win the Premier League Golden Boot. Hi...

2023-01-13 22:23 6294

SD Biosensor Successfully Finishes JP Morgan Healthcare Conference

* Entering the US market in earnest by acquiring Meridian * Expanding into a direct sales system in 10 countries within the year * Launching plans, including the new product, 'STANDARD M10 FAST RT-PCR, CGMS' SEOUL, South Korea, Jan. 13, 2023 /PRNewswire/ -- SD Biosensor, Inc. (KS137310), Sou...

2023-01-13 15:11 2273

SD Biosensor Successfully Finishes JP Morgan Healthcare Conference

TPIsoftware's AI-Powered SysTalk.Chat to Elevate Chang Gung Memorial Hospital's Customer Services

TAIPEI, Jan. 13, 2023 /PRNewswire/ -- Taking the trophy as the one of the best products inTaiwan at Taiwan Excellence Awards 2023, TPIsoftware's SysTalk.Chat , the conversational AI chatbot, has reached new heights in driving smart healthcare ...

2023-01-13 11:11 3286

Accor reveals its thought-leading Health to Wealth white paper

A ROAD MAP TOWARDS A TRANSFORMATIONAL WELL-BEING CULTURE PARIS, Jan. 12, 2023 /PRNewswire/ -- Accor, a world-leading hospitality group, today announced the release of its highly anticipated white paper, exploring eight key pathways for navigating business, society and leadership toward a future ...

2023-01-12 20:01 4341

Accor reveals its thought-leading Health to Wealth white paper

adm Group appoints Justin Barton as Executive Chairman and Ed Colflesh as Global CEO

LONDON, Jan. 12, 2023 /PRNewswire/ -- adm Group, a global marketing execution partner to the world's leading brands, today announces the appointment of current Global CEO,Justin Barton, as Executive Chairman. Justin has been CEO of adm since 2014. He has overseen a significant expansion of the bu...

2023-01-12 17:00 2725

adm Group appoints Justin Barton as Executive Chairman and Ed Colflesh as Global CEO

DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS

- Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. - Debiopharm is developing Debio 4126, a novel 3-month ext...

2023-01-12 17:00 1663

JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA

SINGAPORE, Jan. 12, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd , a science-led healthcare company focused on commercialising novel therapies, has been granted distribution rights forCaris Life Sciences®

2023-01-12 13:02 2315

iNtRON is finalizing the SAL200 Tech Transfer

* Including the contract transfers of the external studies planned for the successful out-licensing and commercialization of SAL200 BOSTON and SEOUL, South Korea, Jan. 11, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today...

2023-01-12 09:34 1797

DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS

2023-01-12 06:00 2549

CGTN: TCM continues to play significant role in treating COVID-19

BEIJING, Jan. 11, 2023 /PRNewswire/ -- Traditional Chinese Medicine (TCM) has been playing an important role inChina's fight against COVID-19. As China is shifting the focus of its COVID-19 response from preventing infections to protecting people's health and preventing severe cases, the unique...

2023-01-11 23:09 3178

Meihua International Medical Technologies Co., Ltd. Enters into Strategic Partnership with Getein Biotech Inc. to Jointly Produce and Sell Covid-19 Antigen Test Kits and IVDs

YANGZHOU, China, Jan. 11, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today announced the Company's s...

2023-01-11 21:30 2971

Verana Health Receives New Product Innovation Award from Frost & Sullivan for Its VeraQ Population Health Data Engine

VeraQ's powerful capabilities help to generate real-world evidence, advance therapeutic insights, enable quality measures reporting, enhance patient recruitment and engagement, and reduce trial costs. SAN ANTONIO, Jan. 11, 2023 /PRNewswire/ -- Recently, Frost & Sullivan analyzed the real-world e...

2023-01-11 21:00 2016

Verana Health Receives New Product Innovation Award from Frost & Sullivan for Its VeraQ Population Health Data Engine

Fosun International Receives Four Awards from Corporate Governance Asia

Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International winAsia's Best CEO from Corporate Governance Asia Fosun International also receives Asia's Best CSR and Best Corporate Communications Awards HONG KONG, Jan. 11, 2023 /PRNewswire/ -- On 11 January 2023, the Corpora...

2023-01-11 19:08 6628

Global Times: Connected in recognition: Foreign ambassadors signal a welcome for China's optimized, responsible COVID policy

BEIJING, Jan. 11, 2023 /PRNewswire/ -- As of January 8, China downgraded the management of COVID-19 from category A to the less serious category B infectious disease in light of the evolving epidemic. The Chinese government has optimized measures to combat the epidemic in accordance with the soci...

2023-01-11 18:24 1810

Global Times: 'Zhang Wenhong phenomenon' shows inclusiveness of China's public opinion sphere; policymaking based on science helps nation firmly hold strategic initiative of epidemic fight

BEIJING, Jan. 11, 2023 /PRNewswire/ -- On Friday, China released the 10th edition of the COVID-19 prevention and control protocol. Moreover, starting from Sunday, the country downgraded the management of COVID-19 from Class A to Class B and lifted quarantine requirements for inbound travelers. Th...

2023-01-11 17:49 1596

Manulife Named by HR Asia Among "Best Companies to Work for" Across Five Markets

HONG KONG, Jan. 11, 2023 /PRNewswire/ -- Manulife has been recognized by HR Asia as one of the "Best Companies to Work for inAsia 2022" in five of the company's Asian markets --China, Hong Kong, Malaysia, Singapore and Vietnam -- because of its excellence in promoting colleague engagement and wor...

2023-01-11 12:00 3355

TPIsoftware's AI-Powered SysTalk.Chat to Elevate Chang Gung Memorial Hospital's Customer Services

TAIPEI, Jan. 11, 2023 /PRNewswire/ -- Taking the trophy as the one of the best products inTaiwan at Taiwan Excellence Awards 2023, TPIsoftware's award-winning SysTalk.Chat , the conversational AI chatbot, has reached new heights in driving the...

2023-01-11 11:20 2530

Bio4t2 announces first patient infused with CAR-T targeting solid tumors

SAN DIEGO, Jan. 11, 2023 /PRNewswire/ -- Bio4t2 dosed the first patient with T cells bearing a chimeric antigen receptor (CAR) that targets overexpression of BT-001 antigen present on various types of solid tumors. The CAR-T (B4t2-001) was developed from Bio4t2's PrismCore™ platform. "This first...

2023-01-11 09:00 2222

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval

GENEVA, Jan. 11, 2023 /PRNewswire/ -- SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronaryde novo lesions.

2023-01-11 09:00 2663

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval

Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

* Samsung Biologics is one of 19 companies to have been awarded the 2022 Terra Carta Seal. * The Terra Carta Seal recognises global companies which are driving innovation and demonstrating their commitment to, and momentum towards, the creation of genuinely sustainable markets. * Designed b...

2023-01-11 08:01 2093

1 ... 210 211 212213214 215 216 ... 808